NEW: Prof Matteo Bertini’s comment on this edition of the ClinicalEVIDENCE newsletter:
Matteo Bertini, M.D, PhD, FAIAC
Professor of Cardiology, Head of EP lab, Cardiological Center, Sant’ Anna University Hospital
“In Italy, the adherence to remote monitoring (RM) consensus statement for CIEDs in clinical practice still need improvement. Only 73% of the patients receive RM prior to discharge and connectivity is difficult to control and it seems low for many patients. Furthermore, alert-based RM should be the optimal for the patients but needs personalization for every single patient and centers still seem to be far from this point!
Real-time Remote Technical Support for CIED Follow-up was proved to be feasible, effective, and well-accepted by operators, offering a viable to support both scheduled and unscheduled follow-up visits. Now we have an alternative to deal with daily organizational problems!
The sub-analysis of the PRAETORIAN Trial highlighted once again that there are no significant differences in inappropriate therapies rates between S-ICD and TV-ICD in a conventional ICD population.”
Summary
This edition of Clinical Evidence reviews adherence to remote monitoring (RM) recommendations in CIEDs follow-up and innovations to enhance this technology, focusing on Heart Connect's preliminary experience. It also explores findings from a sub-analysis of the PRAETORIAN study.
An analysis¹ of LATITUDE™ RM system data shows growing RM use but highlights critical aspects for effective clinical practice with high volumes of visits. Heart Connect, a real-time remote technical support service, has proven² feasible, effective, and well-accepted for providing prompt support during in-person CIED follow-up. The PRAETORIAN sub-analysis³ demonstrated comparable rates of inappropriate therapies between S-ICD and TV-ICD in the conventional ICD population, though these results should be reconsidered with recent S-ICD advancements.
Key Takeaways
- Adherence to remote monitoring guidelines for CIEDs in clinical practice: RM use is growing in clinical practice, but critical issues remain for its effectiveness, efficiency, and sustainability in real-life. To address these challenges and improve its use, innovative solutions have been introduced to support physicians¹.
- Real-time Remote Technical Support for CIED Follow-up: Remote support using HeartConnect™ during CIED follow-up proved feasible, effective, and well-accepted by operators, offering a viable alternative to on-site IEAPs support for follow-up visits².
- Insights from the PRAETORIAN Trial: This multicenter randomised study found no significant difference in inappropriate therapy rates and IAS rates between the S-ICD and TV-ICD in a conventional ICD population³.
Gain deeper insights by downloading the full newsletter
